Bayer plans to spend $1 bln on US pharma R&D in 2023-US pharma head
Bayer AG (BAYGn.DE) plans to spend $1 billion on drug research and development in the US this year as it works to double its sales in the country by the ...
Stay up to date with the latest health news, wellness advice, medical research, and public health updates in Cyprus and around the world.